Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH UNICHEM LAB PROCTER & GAMBLE HEALTH/
UNICHEM LAB
 
P/E (TTM) x 34.5 236.1 14.6% View Chart
P/BV x 10.5 1.4 740.8% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   UNICHEM LAB
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
UNICHEM LAB
Mar-23
PROCTER & GAMBLE HEALTH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs5,366467 1,149.0%   
Low Rs3,883226 1,718.1%   
Sales per share (Unadj.) Rs740.7190.7 388.3%  
Earnings per share (Unadj.) Rs138.2-28.7 -481.3%  
Cash flow per share (Unadj.) Rs155.2-12.6 -1,230.5%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6344.2 130.1%  
Shares outstanding (eoy) m16.6070.41 23.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.21.8 343.7%   
Avg P/E ratio x33.5-12.1 -277.3%  
P/CF ratio (eoy) x29.8-27.5 -108.5%  
Price / Book Value ratio x10.31.0 1,026.1%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,76124,396 314.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0623,564 57.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29613,430 91.6%  
Other income Rs m184385 47.7%   
Total revenues Rs m12,48013,815 90.3%   
Gross profit Rs m3,247-841 -386.0%  
Depreciation Rs m2811,134 24.8%   
Interest Rs m8173 4.4%   
Profit before tax Rs m3,142-1,764 -178.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847259 327.6%   
Profit after tax Rs m2,295-2,022 -113.5%  
Gross profit margin %26.4-6.3 -421.6%  
Effective tax rate %27.0-14.7 -183.9%   
Net profit margin %18.7-15.1 -123.9%  
BALANCE SHEET DATA
Current assets Rs m11,71315,885 73.7%   
Current liabilities Rs m6,7916,396 106.2%   
Net working cap to sales %40.070.7 56.7%  
Current ratio x1.72.5 69.4%  
Inventory Days Days26351 513.0%  
Debtors Days Days3431,600 21.5%  
Net fixed assets Rs m10,61715,911 66.7%   
Share capital Rs m166141 117.9%   
"Free" reserves Rs m7,26524,092 30.2%   
Net worth Rs m7,43124,233 30.7%   
Long term debt Rs m0636 0.0%   
Total assets Rs m22,33031,829 70.2%  
Interest coverage x409.1-9.2 -4,452.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 130.5%   
Return on assets %10.3-5.8 -177.5%  
Return on equity %30.9-8.3 -370.1%  
Return on capital %42.4-6.4 -662.8%  
Exports to sales %069.7 0.0%   
Imports to sales %13.112.4 105.1%   
Exports (fob) Rs mNA9,366 0.0%   
Imports (cif) Rs m1,6051,669 96.2%   
Fx inflow Rs m1,4659,366 15.6%   
Fx outflow Rs m1,6051,669 96.2%   
Net fx Rs m-1407,697 -1.8%   
CASH FLOW
From Operations Rs m2,360-851 -277.4%  
From Investments Rs m-2152,028 -10.6%  
From Financial Activity Rs m-985-813 121.1%  
Net Cashflow Rs m1,160746 155.6%  

Share Holding

Indian Promoters % 0.0 70.2 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 11.3 179.1%  
FIIs % 7.6 0.8 904.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 29.8 161.8%  
Shareholders   56,730 20,877 271.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Unichem Lab Share Price Performance

Period Procter & Gamble Health Unichem Lab S&P BSE HEALTHCARE
1-Day -0.55% 1.90% 1.18%
1-Month -7.47% -5.40% -0.75%
1-Year -3.02% 78.12% 61.82%
3-Year CAGR -9.12% 16.06% 18.16%
5-Year CAGR 5.75% 19.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Unichem Lab the stake stands at 70.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.